QuarkMed
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- Undisclosed
Investors
- 3
About QuarkMed
Based in Beijing, China, and founded in 2022, QuarkMed operates as a CRO (Contract Research Organization) service company that focuses on providing nuclear medicine clinical CRO services. The company has branches and offices in Shanghai, Guangzhou, Hangzhou, Chengdu and other regions. The general manager, Dawei Y, graduated from Tsinghua University and Indiana University. It has cooperated with Forward, Deepwise, Yunnan Baiyao, United Imaging, and other enterprises. In 2023, the company became a member of the Radiopharmaceutical Branch of the Chinese Nuclear Society. The company's business include drug and device clinical research, data management and statistical analysis, SMO (Site Management Organization), etc. Other services include drug and device registration, clinical operations, post-marketing studies and pharmacoeconomic evaluation. Its services cover nuclear medicine, cell therapy, cardiovascular and cerebrovascular, oncology, respiratory, neuropsychiatric and other fields. QuarkMed generates revenue by providing drug and device clinical research, data management and statistical analysis, and SMO services. The company will continue to improve its radiopharmaceutical service chain and comprehensive clinical research capabilities.
Who invested in QuarkMed
3 investors across 1 round
See all investors in QuarkMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 11, 2024
Amount
Undisclosed
Investors
Questions about QuarkMed
Who invested in QuarkMed?
QuarkMed has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has QuarkMed raised?
QuarkMed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did QuarkMed last raise money?
QuarkMed's most recent round on record is a Series A, in Oct 2024.
What does QuarkMed do?
Based in Beijing, China, and founded in 2022, QuarkMed operates as a CRO (Contract Research Organization) service company that focuses on providing nuclear medicine clinical CRO services.
Where is QuarkMed headquartered?
QuarkMed is headquartered in Beijing, China.
Which VCs invest in companies like QuarkMed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at QuarkMed's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like QuarkMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.